Rynatan Pediatric Suspension
Generic name:phenylephrine tannate and chlorpheniramine tannate
Dosage form: oral suspension
Drug class:Upper respiratory combinations
Medically reviewed by Drugs.com. Last updated on May 23, 2022.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
On This Page
The Rynatan Pediatric brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Description
Rynatan® Pediatric Suspension is an antihistamine/nasal decongestant combination available for oral administration as a Suspension. Each 5 mL (one teaspoonful) of the slate-purple-colored, natural strawberry- artificial currant flavored Suspension contains:
Phenylephrine Tannate 5 mg
Chlorpheniramine Tannate 4.5 mg
Other ingredients: benzoic acid, FD&C Blue No.1, FD&C Red No. 3, FD&C Red No. 40, FD&C Yellow No. 5 (see Precautions), flavors (natural and artificial), glycerin, kaolin, magnesium aluminum silicate, methylparaben, pectin, purified water, saccharin sodium, sucrose.
Clinical Pharmacology
Rynatan® Pediatric Suspension combines the sympathomimetic decongestant effect of phenylephrine with the antihistaminic action of chlorpheniramine.
Indications and Usage
Rynatan® Pediatric Suspension is indicated for symptomatic relief of the coryza and nasal congestion associated with the common cold, sinusitis, allergic rhinitis and other upper respiratory tract conditions. Appropriate therapy should be provided for the primary disease.
Contraindications
Rynatan® Pediatric .
